Dann Bruno

Dann Bruno represents PE and VC firms and high-growth life sciences and technology companies, from early-stage startups to pre-IPO companies to global enterprises. Dann has served as company counsel to numerous VC and PE backed companies in their early-stage and growth equity financings. With extensive experience in M&A, PE, VC and growth-stage financings across the spectrum of life sciences, biotech, healthcare IT and other technology companies, clients describe Dann as responsive and efficient and able to provide strategic and practical business-focused advice.

Dann regularly advises on a wide range of transactional and corporate law matters, ranging from M&A, strategic financings, licensing and day-to-day corporate governance matters across a broad range of industries, including the technology, healthcare and life sciences sectors. Dann is also admitted to practice before the U.S. Patent & Trademark Office and leverages his science background to assist clients with intellectual property matters and transactions. Representative clients include Surveyor Capital (a Citadel company), Andressen Horowitz, Sectoral Asset Management, Sverica Capital, Victress Capital, XPV Water Partners, ArcLight Capital and Perceptive Xontogeny Ventures.


  • Best Lawyers in America: “Ones to Watch (2021-2023)

Representative Engagements

  • Represented Sverica Capital portfolio company Gorilla Logic in their acquisition of Modernist Studio (design and ideation boutique) and Cytracom in their acquisition of Omninet (cyber security and connectivity).
  • Represented Andreesen Horowitz in numerous early-stage biotech, healthcare IT, gaming and technology investments.
  • Represented Surveyor Capital (a Citadel company) in numerous life sciences pre-IPO crossover financings, including Vanqua Bio, Attralus, Neumora Therapeutics, Ventyx Biosciences, Expansion Therapeutics, Acelyrin, Quanta Therapeutis, Arbor Bio, Korro Bio, Acrivon, Neuron23, Gennao Bio, Ambagon Therapeutics, ImmPACT Bio, Metagenomi, Arkuda Therapeutics, Triana Bio, Emergence Therapeutics, Plexium, OnKure Therapeutics, Remix Therapeutics and ShouTi.
  • Represented Hannon Armstrong in Series B financing of REsurety (market intelligence and technology provider for clean energy industry).
  • Represented Creation Technologies International in their take-private acquisition of IEC Electronics Corp. (NASDAQ: IEC) (electronic manufacturing services to medical, industrial, aerospace and defense sectors).
  • Represented ArcLight Capital in their growth-equity financing of Zeem Solutions (modular EV and clean technology company).
  • Represented Xontogeny and Perceptive Xontogeny Ventures in numerous early-stage biotech financings, including PolyCore Therapeutics, Peroxitech, Sermonix Pharmaceuticals, VivoSense Therapeutics, Surf Bio.
  • Represented Sectoral Asset Management in growth equity investments in biotech therapeutics companies.
  • Represented Victress Capital in numerous early-stage (primarily female and minority founded) consumer-focused technology investments, including: Droplette (skincare technology), Lucra Sports (gaming and fantasy sports platform).
  • Company counsel to XPV portfolio company Soli Organic (soil-based indoor organic farming) in their $100+ million growth equity financing.
  • Company counsel for stealth-mode blockchain payment technology company in their $25+ million early stage financing co-led by strategic and financial investors and general counsel.
  • Represented Drive Capital in connection with numerous technology investments, including their Series B investment in Gecko Robotics (industrial robotics).
  • Company counsel to gene therapy biotech company in their multi-billion dollar sale to a publicly listed German based acquirer and general counsel.
  • Company counsel to Forge Biologics (gene therapy biotech) in their $40+ million Series A and $80+ Series B financings and general counsel.
  • Company counsel to Olive (healthcare IT and AI) in their $50+ million Series E financing and general counsel.
  • Company counsel to Circulo (healthcare IT and insurtech) in their $50 million Series A financing and strategic partnership.
  • Company counsel to Enlace Health (f/k/a Aver) in their $25+ million Series C financing and general counsel.
  • Represented High Alpha in connection with numerous early-stage B2B SaaS investments and portfolio companies.
  • Company counsel to 80 Acres (indoor vertical farming) in connection with $40+ million Series A financing.
  • Company counsel to CinCor Pharma (small molecule biotech) in connection with $50 million Series A financing.

Professional & Community Involvement

  • Tenant Advocacy Program

Education & Credentials

The University of Akron School of Law
JD, 2015, magna cum laude
Intellectual Property & Business
The Ohio State University
BS, 2008, summa cum laude
Biology: Anatomy & Physiology




U.S. Patent & Trademark Office